Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell Disease

March 2, 2022

View Press Release Corporate presentation Contact us
Previous